Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l-Reference-Cited by-同舟云学术

Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l

Published:2007-11-27 Issue:6 Volume:51 Page:911-915
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Van den Berghe G.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-007-0878-7.pdf

Reference35 articles.

1. Miles J, McMahon MM, Isley WL (2007) No, the glycaemic target in the critically ill should not be ≤6.1 mmol/l. Diabetologia DOI 10.1007/s00125-007-0888-5

2. Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367

3. Van den Berghe G, Schoonheydt K, Becx P et al (2005) Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64:1348–1353

4. Van den Berghe G, Wouters PJ, Kesteloot K et al (2006) Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med 34:612–616

5. Ingels C, Debaveye Y, Milants I et al (2006) Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care and quality of life. Eur Heart J 27:2716–2724

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preemptive Bundle Therapy for Subclinical Pulmonary Hypertension After Liver Transplant;Experimental and Clinical Transplantation;2021-11

2. Safety of artificial pancreas in hepato-biliary-pancreatic surgery: A prospective study;Asian Journal of Surgery;2020-01

3. Diabètes secondaires;Diabetologie;2019

4. Efficacy of an artificial pancreas device for achieving tight perioperative glycemic control in living donor liver transplantation;Artificial Organs;2018-11-15

5. Diabetes diagnostics including analytical methods for glucose monitoring;Point-of-Care Testing;2018